Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies: Tim Cowper, Jordan Herman

Tim Cowper has become CFO and Jordan Herman general counsel of Oxford Nanopore Technologies.

Chowper joined the company in 2012 as commercial operations director after acting as interim finance director for several months in 2009. He became VP of finance in 2017. Previously, he was finance director at British Biotech and at Clipper Ventures, he cofounded Sterilox, and he was financial controller at Celltech.

Herman joins Oxford Nanopore from Baker Botts, where he was a partner and acted as Oxford's outside counsel for more than a decade. He holds a JD from Ohio State University and a degree in political economy from Washington University.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.